![]() |
![]() |
![]() |
![]() |
|||||||||||||||||||||||||||||||
|
Vol.V Issue: I: (JSRM code: 005010300005) |
|||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
Abstract Key words:? Introduction Adipose stromal cells (ASCs) isolated from fat are a readily available source of autologous stem/progenitor cells. ASCs exhibit pluripotency having been shown to develop into myogenic, adipogenic, neurogenic, osteogenic, chondrogenic endothelial and hepatic cells3,6,9,12,14-17,19-23 in vitro. In addition, ASCs in culture include a significant percentage of highly proliferative cells enabling rapid expansion of pluripotent cells in vitro. Several recent publications suggest their potential value as a source of autologous, adult progenitors for cell therapy applications2,4,5,7,8,13,18,23,24. To realize that potential, considerable effort has focused on identifying and understanding the factors that affect their proliferation and differentiation. These include the effects of media components and other cell culture parameters. In addition, there are likely unknown genetic factors influencing the behavior of ASCs. It has long been recognized that individuals with the same genotype at particular genes of interest, often manifest variable phenotypes. While some of this variation reflects stochastic or environmental factors, part is attributable to the variation at other genetic loci that modify the biological process involved in the expression of the phenotype. The aim of this study was to determine whether properties related to the efficacy of stem/progenitor cells for cell therapy are affected by genetic background. If so, the identification of such genetic factors might suggest strategies to improve such protocols. The role of modifier loci and genetic background is most pronounced in the phenotypic differences observed between animals of different inbred strains that have the same genotype at loci of interest. It is likely that these phenotypic strain differences extend to the properties of stem/progenitor cells. With the genomic tools that are now available, significant strain differences provide the opportunity to identify modifier loci affecting biomedically important biological processes. Identifying genetic factors affecting the behavior of ASCs might identify new targets to improve the efficacy of ASCs for cell therapy applications as well as to control the generation of adipose tissue. The goal of the work described in this manuscript is to identify proliferative properties of ASCs that vary between inbred mouse strains. Materials and Methods Animals: C57Bl/6j and 129x1/svj mice were purchased from Harlan (Indianapolis, IN) and housed at the LARC animal facility at IUPUI with continuous access to conventional mouse chow. Before harvest of adipose tissue mice were anaesthetized and euthanized in accordance with practices approved by the Institutional Animal Care and Use Committee of IUPUI. Cell Isolation: ASCs were isolated from mouse inguinal and lateral abdominal fat of C57BL/6J and 129x1SVJ 6-week old male. Fat tissue was washed extensively with sterile phosphate-buffered saline (PBS) and cut into tiny pieces with scissors. Washed aspirates were treated with 0.075% type I collagenase (Sigma, St. Louis, MO) in DMEM for 25 min at 37°C with gentle agitation. After digestion, mixtures were centrifuged at 500 rpm for 5 minutes. The supernatant was discarded and the pellets were pipetted and incubated in red cell lysis buffer for 5 minutes at 37°C. After centrifugation at 500 rpm for 5 minutes, cell pellets were gently agitated in DMEM with 10% FBS and filtered through a 40-μm cell strainer (BD Labware) The cell population was transferred into T75 flasks. Theses cells were incubated in Myelocult (M5300, Stemcell Technologies, CA ) for 12-24 hours. Unattached cells were discarded with the first change of media. The attached cell population was used for subsequent analysis. Mouse ASCs were cultured in MyeloCult medium at 37°C 5% CO2. Cells were passaged when approximately 85% confluent and the media changed twice a week. Determining frequency of high proliferative cells: To determine the frequency of high proliferative cells, primary ASCs that attached to the surface of the T75 flask after 12 hour incubation were trypsinized with 0.05% Trypsin-EDTA (Gibco, 25300) and plated directly onto 48-well plates at a density of 10 cells/well. Cells were cultured for 9-11 days and media changed twice a week. The number of wells containing less than 100 cells were counted and used to determine the frequency of wells with no high proliferative cells. Using a Poisson distribution, one could calculate the average number of high proliferative cells per well. Results Percentage of Proliferative cells. Thus N, the number of proliferative cells (among the 10 cells plated per well) is N= -ln(P(0)) and the frequency of proliferative cells, f(pc) is the number of proliferative cells among the 10 cells in a well (f(pc) = N/10) Using this assay, the frequency of high proliferative cells was determined for ASCs isolated from adipose tissue from two strains of mice. The frequency of high proliferative cells among ASCs isolated by attachment to the plastic culture dish in the 129x1/svj strain was significantly greater than that of ASCs isolated from C57Bl/6 (19.1% vs 6.9%, p 0.01). (Table 1., Fig. 1). Case et al. (2005)1 described the isolation of common pluripotent stem cells (coPSC) from muscle and adipose tissue. These cells formed colonies derived from a single cell and maintained pleuripotency. Descendants of a significant number of colony forming cells maintained the ability to develop into multiple cell types including, adipocytes, neural cells and myocytes. These cells were identified out of a population of CD45-Sca-1+c-kit-Thy-1+ isolated from either skeletal muscle or adipose tissue. Since the percentage of high proliferative cells in fat varied with strain, we wished to determine if the frequency of CD45-Sca-1+c-kit-Thy-1+ cells also differed between strains. After the digestion of fat tissue, the stromal cell population was isolated and the percentage of CD45-Sca-1+c-kit-Thy-1+ cells determined by flow cytometry. Consistent with the data on proliferative cells, 129x1/svj mice contained a higher percentage of CD45-Sca-1+c-kit-Thy-1+ than C57Bl/6J mice (12.2% vs 3.4%; p<0.05). Proliferative potential. Discussion By understanding the factors that control the properties and behavior of stem/progenitor cells, it might be possible to improve their efficacy for cell theray applications. Most attention focuses on environmental factors such as media components, growth factors, matrix composition and oxygen tension. However, genetic factors likely play an important role. Mesenchymal stromal cells isolated from bone marrow of different mouse strains have been shown to have different developmental potential and respond differently to various media formulations10,11. In this report, we show that the frequency of high proliferative cells within ASC populations isolated by two different methods is higher in the 129x1/svj strain that in C57Bl/6J mice. These differences are statistically significant as the variation among mice in each strain is less than the difference between strains. While the frequency of proliferative cells is different, there does not appear to be a difference in the proliferative potential among individual clones from each strain in ex vivo cell culture. The proliferation of these murine cells is quite limited; the clonal lines can only be passaged approximately 7 times before the cells become senescent. This limited propagation of murine ASCs is unlike the proliferative potential of ASCs isolated from other species including humans and rats. Conceivably, since the lifespan of mice is quite short, there is no selection to maintain high proliferative capacity of a progenitor cell population. Similar observations have been observed with endothelial progenitor cells where it is much more difficult to isolate highly proliferative endothelial progenitors in mice than many other species (M. Yoder, personal communication). The strain differences in the frequency of proliferative cells among ASCs suggest that genetic modifier loci influence the frequency of stem progenitor cells. Although the identity of these loci is unknown, it is possible that selective backcrossing of 129x1/svj:C57Bl/6J hybrids that have a high frequency of proliferative ASCs, into a C57Bl/6J background could enrich for 129x1/svj derived loci that effect the percentage of proliferative progenitor cells. The identification of such loci could provide important therapeutic targets to increase the regenerative potential of damaged tissue. Conclusion and/or Summary Acknowledgements The authors thank Amy Zollman for managing the relevant mouse colonies. The work was supported by the Indiana Genetics Initiative (INGEN) and NIH grant HL073750 to EDR. Figure 1
Figure 1. Percentage of Proliferative Cells Among ASCs in 129x1SVJ and C57Bl/6J. ASCs were isolated from 6 129x1svj and 9 C57Bl/6J males and plated at 10 cells per well in a total of 40 wells. The percentage of high proliferative cells among the ASCs is more than 2 fold greater in 129x1/svj than C57Bl/6J mice (19% vs 6.9%; p<0.01) (See Table 1 and text for details). Figure 2 |
||||||||||||||||||||||||||||||||||
Cover Image:
Figure 2. Limited Proliferative Poltential of Murine ASCs. Photomicrographs of C57Bl/6J ASCs growing in Myleocult (Stem Cell Technology, CA) after passage 2 (frame A) and passage 6 (frame B). Early passage cells maintain fibroblast-like morphology; later passage cells are senescent and stop proliferating. Similar results are obtained for ASCs from 129x1/svj mice. |
||||||||||||||||||||||||||||||||||
Table 1
Table 1. Percentage of Proliferative Cells Among ASCs in 129x1SVJ and C57Bl/6J. ASCs were isolated from 6 129x1svj and 9 C57Bl/6J males and plated at 10 cells per well in a total of 40 wells. The number of wells in which there was no appreciable growth (< 100 cells) were recorded. The number of proliferative cells in each well (N) was calculated using the Poisson distribution where N=-ln(P(0)) where P(0) is the fraction of wells with no significant cell growth (see text). Results are plotted in Figure 1. References 1. Case J, Horvath TL, Howell JC, Yoder MC, March KL, Srour EF. Clonal multilineage differentiation of murine common pluripotent stem cells isolated from skeletal muscle and adipose stromal cells. Ann N Y Acad Sci. 2005. 1044:183-200 2. Cowan CM, Shi YY, Aalami OO, Chou YF, Mari C, Thomas R, Quarto N, Contag CH, Wu B, Longaker MT. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol. 2004. 22:560-567 3. Halvorsen YC, Wilkison WO, Gimble JM. Adipose-derived stromal cells--their utility and potential in bone formation. Int J Obes Relat Metab Disord. 2000. 24 Suppl 4:S41-44 4. Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol. 2003. 183:355-366 5. Kim SJ, Cho HH, Kim YJ, Seo SY, Kim HN, Lee JB, Kim JH, Chung JS, Jung JS. Human adipose stromal cells expanded in human serum promote engraftment of human peripheral blood hematopoietic stem cells in NOD/SCID mice. Biochem Biophys Res Commun. 2005. 329:25-31 6. Kras KM, Hausman DB, Hausman GJ, Martin RJ. Adipocyte development is dependent upon stem cell recruitment and proliferation of preadipocytes. Obes Res. 1999. 7:491-497 7. Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, Bouloumie A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation. 2004. 110:349-355 8. Mosca JD, Hendricks JK, Buyaner D, Davis-Sproul J, Chuang LC, Majumdar MK, Chopra R, Barry F, Murphy M, Thiede MA, Junker U, Rigg RJ, Forestell SP, Bohnlein E, Storb R, Sandmaier BM. Mesenchymal stem cells as vehicles for gene delivery. Clin Orthop Relat Res. 2000. S71-90 9. Ogawa R, Mizuno H, Watanabe A, Migita M, Shimada T, Hyakusoku H. Osteogenic and chondrogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice. Biochem Biophys Res Commun. 2004. 313:871-877 10. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. 2004. 103:1662-1668 11. Phinney DG, Kopen G, Isaacson RL, Prockop DJ. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem. 1999. 72:570-585 12. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Penicaud L, Casteilla L. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004. 109:656-663 13. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004. 109:1292-1298 14. Safford KM, Hicok KC, Safford SD, Halvorsen YD, Wilkison WO, Gimble JM, Rice HE. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun. 2002. 294:371-379 15. Sen A, Lea-Currie YR, Sujkowska D, Franklin DM, Wilkison WO, Halvorsen YD, Gimble JM. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem. 2001. 81:312-319 16. Seo MJ, Suh SY, Bae YC, Jung JS. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun. 2005. 328:258-264 17. Stashower M, Smith K, Williams J, Skelton H. Stromal progenitor cells present within liposuction and reduction abdominoplasty fat for autologous transfer to aged skin. Dermatol Surg. 1999. 25:945-949 18. Strem BM, Hedrick MH. The growing importance of fat in regenerative medicine. Trends Biotechnol. 2005. 23:64-66 19. Strem BM, Zhu M, Alfonso Z, Daniels EJ, Schreiber R, Begyui R, Maclellan WR, Hedrick MH, Fraser JK. Expression of cardiomyocytic markers on adipose tissue-derived cells in a murine model of acute myocardial injury. Cytotherapy. 2005. 7:282-291 20. Van Harmelen V, Rohrig K, Hauner H. Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism. 2004. 53:632-637 21. Wabitsch M, Brenner RE, Melzner I, Braun M, Moller P, Heinze E, Debatin KM, Hauner H. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord. 2001. 25:8-15 22. Yang LY, Liu XM, Sun B, Hui GZ, Fei J, Guo LH. Adipose tissue-derived stromal cells express neuronal phenotypes. Chin Med J (Engl). 2004. 117:425-429 23. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002. 13:4279-4295 24.Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering. 2001. 7:211-228 |
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||